Commercial Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool BioPharma DiveSome 1,390 Foundayo prescriptions were written in two days, according to analysts.CommercialMetabolic & GLP-1Read full story pharminent April 17, 2026 (Last updated: April 17, 2026) BioPharma Dive Some 1,390 Foundayo prescriptions were written in two days, according to analysts. CommercialMetabolic & GLP-1Read full story Post navigation Previous: Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launchNext: Kailera makes history with record-breaking $625m IPO Related Stories Commercial Novo’s CEO champions “record-breaking start” for Wegovy pill in US market pharminent May 8, 2026 Commercial Novo hikes guidance on Wegovy pill’s fast sales start pharminent May 6, 2026 Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
